Search
for
Sort by
Research 241–270 of 280
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Skin amidst COVID ‐19 pandemic
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- ANDROGENŲ IR ANDROGENINĖS ALOPECIJOS RYŠYS SU COVID-19 INFEKCIJA
- Human genetic basis of coronavirus disease 2019
- Candidate genes of SARS-CoV-2 gender susceptibility
- Host Genetic Susceptibility and Impacts of Dietary Factors on Covid-19
- The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- Untangling the hairy issue of iron deficiency: Making progress
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- O papel dos andrógenos na alopecia androgenética associada à gravidade do COVID-19
- Growth retardation and hair loss in transgenic mice overexpressing human H-ferritin gene
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Acute and Chronic Telogen Effluvium
- Acute and Chronic Telogen Effluvium
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- Effect of Epipharyngeal Abrasive Therapy on Long COVID with Chronic Epipharyngitis
- Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids
- Symptom Trajectories and Long-Term Sequelae of COVID-19: A Matched Case–Control Study with Population-Based Controls
- Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case–Control Study